Halma plc 37.4% Potential Decrease Indicated by JP Morgan Cazenove

Broker Ratings
[shareaholic app="share_buttons" id_name="post_below_content"]

Halma plc with EPIC/TICKER (LON:HLMA) has had its stock rating noted as ‘Reiterates’ with the recommendation being set at ‘UNDERWEIGHT’ today by analysts at JP Morgan Cazenove. Halma plc are listed in the Industrials sector within UK Main Market. JP Morgan Cazenove have set a target price of 1460 GBX on its stock. This now indicates the analyst believes there is a potential downside of -37.4% from today’s opening price of 2334 GBX. Over the last 30 and 90 trading days the company share price has increased 45 points and increased 385 points respectively. The 52 week high for the share price is currently at 2377 GBX while the 52 week low for the stock is 1660 GBX.

Halma plc has a 50 day moving average of 2,270.96 GBX and a 200 day moving average of 2,104.77. There are currently 379,645,332 shares in issue with the average daily volume traded being 938,839. Market capitalisation for LON:HLMA is £8,864,715,420 GBP.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:
    Halma plc (LON:HLMA) reports strong half-year results, announcing a 7% interim dividend increase, boosting shareholder returns in 2024.
    Halma Plc acquires Lamidey Noury Medical, expanding its healthcare portfolio with advanced electrosurgical devices for minimally invasive procedures.
    Halma plc (LON:HLMA) has released its full year results for the year ending 31 March 2024. Explore the financial details and dividend information here.
    Halma plc (LON: HLMA) releases its trading update for the financial year, showing strong growth and strategic investments. Full year results expected on 13 June 2024.

      Search

      Search